Our Give To Live Society members help St. Jude focus on what matters most.
Kinlee's journey with medulloblastoma shows how research in the labs at St. Jude can translate to better outcomes for patients.
St. Jude scientists helped lead a comprehensive genomic analysis to uncover the impact of genes on the treatment and outcome of the world’s most common childhood cancer.
Pioneering work in St. Jude labs provides "promising" path to a cure using gene editing.
Saving future generations of St. Jude kids
For questions about St. Jude Give To Live Society, call (800) 214-0654, email gtlsocietysupport@alsac.stjude.org, or visit our FAQs.
St. Jude patient Reagan
Other ways to renew your Give To Live Society membership in 2024: